InfuSystem Inc (INFU): רווח למניה בשנים עשר החודשים האחרונים

InfuSystem Holdings (INFU) dominates the outpatient pump service niche, relieving clinics of operational burdens. The business relies on inelastic demand from oncology centers and an extensive network of contracts that blocks smaller players. Tracking the company's net profit per share over 12 months on GURU.Markets, we note that the value 0.45 describes the current yield level, confirming the issuer's financial stability.

The selection of high-quality issuers is based on an analysis of the business's ability to generate real income per security. The rolling annual earnings per share (EPS) on GURU.Markets aggregates net income over four quarters, reflecting the efficiency of the InfuSystem (INFU) logistics platform and the stability of its contracts with US insurance networks, allowing investors to assess the company's fundamental viability through the price action of this chart.